HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ciric To Selected Research
Ciric To Research Topics
Disease
10
Neoplasms (Cancer)
01/2022 - 04/2008
7
Lung Neoplasms (Lung Cancer)
12/2023 - 07/2015
4
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 08/2017
1
Adenocarcinoma of Lung
11/2019
1
Disease Progression
11/2019
1
Carcinogenesis
07/2015
1
Breast Neoplasms (Breast Cancer)
07/2014
Drug/Important Bio-Agent (IBA)
7
ErbB Receptors (EGF Receptor)
IBA
12/2023 - 08/2017
4
Tyrosine Kinase Inhibitors
IBA
01/2022 - 01/2019
4
Triterpenes
IBA
07/2017 - 04/2008
3
Phosphotransferases (Kinase)
IBA
12/2023 - 11/2019
2
osimertinib
IBA
11/2019 - 08/2017
2
1- (2- cyano- 3,12- dioxooleana- 1,9- dien- 28- oyl) imidazole
IBA
07/2015 - 04/2008
2
bardoxolone
IBA
07/2015 - 04/2008
1
Quinazolinones
IBA
01/2022
1
Messenger RNA (mRNA)
IBA
09/2021
1
Erlotinib Hydrochloride (CP 358,774)
FDA Link
11/2019
1
Gefitinib (Iressa)
FDA Link
11/2019
1
Adenosine Triphosphate (ATP)
IBA
01/2019
1
Anaplastic Lymphoma Kinase
IBA
08/2017
1
ceritinib
IBA
08/2017
1
bardoxolone methyl
IBA
07/2015
1
oleanane
IBA
07/2015
1
Dimethyl Fumarate
IBA
07/2015
1
Poly(ADP-ribose) Polymerase Inhibitors
IBA
07/2014
1
veliparib
IBA
07/2014
1
Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)
IBA
07/2014
1
olaparib
IBA
07/2014
1
Transforming Growth Factor beta (TGF-beta)
IBA
04/2008
1
Acids
IBA
04/2008
Therapy/Procedure
6
Therapeutics
01/2022 - 07/2015
1
Chemoprevention
07/2014